Radiopharm Theranostics RADX
NASDAQ RADX
$2.15 +0.09 (+4.36%)
As of: Sep 10, 2026 · 10:29 AM EDT

Radiopharm Theranostics Ltd (RADX) Gross Profit (2024 - 2026)

Radiopharm Theranostics' (RADX) quarterly Gross Profit came in at -$92644.4 in Q2 2026, up 97.37% year-over-year from -$46938.8 in Q2 2025, and up 97.37% quarter-over-quarter from -$3.5 million in Q2 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Radiopharm Theranostics Ltd (RADX) Gross Profit (2024 - 2026) Analysis & Trends

Radiopharm Theranostics (RADX) has reported Gross Profit for 3 consecutive years, with -$92644.4 the latest figure, recorded in Q2 2026.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -92,644.38
Jun 30, 2025 -3.53 Mn
Jun 30, 2024 23,475.11